Current Pharmaceutical Design
Title:Editorial (Thematic Issue: New Trends in Pharmaceutical Nanotechnology)
Volume: 21 Issue: 36
Author(s): Marilene Estanqueiro, M. Helena Amaral and Jose Manuel Sousa Lobo
Affiliation:
Export Options
About this article
Cite this article as:
Estanqueiro Marilene, Amaral Helena M. and Sousa Lobo Manuel Jose, Editorial (Thematic Issue: New Trends in Pharmaceutical Nanotechnology), Current Pharmaceutical Design 2015; 21 (36) . https://dx.doi.org/10.2174/1381612821999150929095516
DOI https://dx.doi.org/10.2174/1381612821999150929095516 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
25
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets
Current Neuropharmacology Molecular Remodeling of the Insulin Receptor Pathway by Thiazolidinediones in Type 2 Diabetes Mellitus: A Brief Review
Protein & Peptide Letters CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment
Current Medicinal Chemistry T11TS/SLFA-3 Differentially Regulate the Population of Microglia and Brain Infiltrating Lymphocytes to Reduce Glioma by Modulating Intrinsic Bcl-2 Expression rather than p53
Central Nervous System Agents in Medicinal Chemistry Morphology of C6 Glioma Cells on a Water-Repellent Fractal Alkyl Ketene Dimer Surface
Current Nanoscience Friend or Foe: UCHL3 Mediated Carcinogenesis and Current Approaches in Small Molecule Inhibitors’ Development
Current Medicinal Chemistry Comparing the Interaction of Cyclophosphamide Monohydrate to Human Serum Albumin as Opposed to Holo-Transferrin by Spectroscopic and Molecular Modeling Methods: Evidence for Allocating the Binding Site
Protein & Peptide Letters The University of New Mexico Center for Molecular Discovery
Combinatorial Chemistry & High Throughput Screening Network Pharmacology of Glioblastoma
Current Drug Discovery Technologies Bioconversion of Isoflavones into Bioactive Equol: State of the Art
Recent Patents on Food, Nutrition & Agriculture Advances Towards The Discovery of GPR55 Ligands
Current Medicinal Chemistry Anlotinib Inhibits Cell Proliferation, Migration and Invasion via Suppression of c-Met Pathway and Activation of ERK1/2 Pathway in H446 Cells
Anti-Cancer Agents in Medicinal Chemistry Molecular Markers of Angiogenesis and Metastasis in Lines of Oral Carcinoma after Treatment with Melatonin
Anti-Cancer Agents in Medicinal Chemistry Genetic and Epigenetic Studies for Determining Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery
Current Pharmaceutical Design Fluorescence-Guided Malignant Glioma Resections
Current Drug Discovery Technologies Regulatory T Cells: Major Players in the Tumor Microenvironment
Current Pharmaceutical Design Is there a Role for Bevacizumab in Non-Glial Tumors?
Current Drug Targets Brain Segmentation Using Deep Neural Networks
International Journal of Sensors, Wireless Communications and Control